Literature DB >> 24336192

Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.

Charlotte Sagne1, Virginie Marcel, Maria Bota, Ghyslaine Martel-Planche, Amanda Nobrega, Edenir Inêz Palmero, Laury Perriaud, Mathieu Boniol, Stephan Vagner, David G Cox, Chang S Chan, Jean-Louis Mergny, Magali Olivier, Patricia Ashton-Prolla, Janet Hall, Pierre Hainaut, Maria Isabel Achatz.   

Abstract

Germline TP53 mutations predispose to multiple cancers defining Li-Fraumeni/Li-Fraumeni-like syndrome (LFS/LFL), a disease with large individual disparities in cancer profiles and age of onset. G-quadruplexes (G4s) are secondary structural motifs occurring in guanine tracks, with regulatory effects on DNA and RNA. We analyzed 85 polymorphisms within or near five predicted G4s in TP53 in search of modifiers of penetrance of LFS/LFL in Brazilian cancer families with (n = 35) or without (n = 110) TP53 mutations. Statistical analyses stratified on family structure showed that cancer tended to occur ~15 years later in mutation carriers who also carried the variant alleles of two polymorphisms within predicted G4-forming regions, rs17878362 (TP53 PIN3, 16 bp duplication in intron 3; P = 0.082) and rs17880560 (6 bp duplication in 3' flanking region; P = 0.067). Haplotype analysis showed that this inverse association was driven by the polymorphic status of the remaining wild-type (WT) haplotype in mutation carriers: in carriers with a WT haplotype containing at least one variant allele of rs17878362 or rs17880560, cancer occurred ~15 years later than in carriers with other WT haplotypes (P = 0.019). No effect on age of cancer onset was observed in subjects without a TP53 mutation. The G4 in intron 3 has been shown to regulate alternative p53 messenger RNA splicing, whereas the biological roles of predicted G4s in the 3' flanking region remain to be elucidated. In conclusion, this study demonstrates that G4 polymorphisms in haplotypes of the WT TP53 allele have an impact on LFS/LFL penetrance in germline TP53 mutation carriers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24336192      PMCID: PMC3977145          DOI: 10.1093/carcin/bgt381

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  44 in total

1.  Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing.

Authors:  Dennis Gomez; Thibault Lemarteleur; Laurent Lacroix; Patrick Mailliet; Jean-Louis Mergny; Jean-François Riou
Journal:  Nucleic Acids Res       Date:  2004-01-16       Impact factor: 16.971

2.  DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.

Authors:  Stéphanie Courtois; Gerald Verhaegh; Sophie North; Maria-Gloria Luciani; Patrice Lassus; Ula Hibner; Moshe Oren; Pierre Hainaut
Journal:  Oncogene       Date:  2002-10-03       Impact factor: 9.867

3.  Modulation of mammalian life span by the short isoform of p53.

Authors:  Bernhard Maier; Wendy Gluba; Brian Bernier; Terry Turner; Khalid Mohammad; Theresa Guise; Ann Sutherland; Michael Thorner; Heidi Scrable
Journal:  Genes Dev       Date:  2004-02-01       Impact factor: 11.361

4.  The Li-Fraumeni syndrome.

Authors:  Agnès Chompret
Journal:  Biochimie       Date:  2002-01       Impact factor: 4.079

5.  p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.

Authors:  Yili Yin; C W Stephen; M Gloria Luciani; Robin Fåhraeus
Journal:  Nat Cell Biol       Date:  2002-06       Impact factor: 28.824

6.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

7.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

Authors:  R C Ribeiro; F Sandrini; B Figueiredo; G P Zambetti; E Michalkiewicz; A R Lafferty; L DeLacerda; M Rabin; C Cadwell; G Sampaio; I Cat; C A Stratakis; R Sandrini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

8.  Regulation of human p53 activity and cell localization by alternative splicing.

Authors:  Anirban Ghosh; Deborah Stewart; Greg Matlashewski
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  A cancer family syndrome in twenty-four kindreds.

Authors:  F P Li; J F Fraumeni; J J Mulvihill; W A Blattner; M G Dreyfus; M A Tucker; R W Miller
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

10.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

View more
  13 in total

1.  Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcripts.

Authors:  Laury Perriaud; Virginie Marcel; Charlotte Sagne; Vincent Favaudon; Aurore Guédin; Aurore De Rache; Corinne Guetta; Florian Hamon; Marie-Paule Teulade-Fichou; Pierre Hainaut; Jean-Louis Mergny; Janet Hall
Journal:  Carcinogenesis       Date:  2014-09-30       Impact factor: 4.944

2.  Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome.

Authors:  Hany Ariffin; Pierre Hainaut; Anna Puzio-Kuter; Soo Sin Choong; Adelyne Sue Li Chan; Denis Tolkunov; Gunaretnam Rajagopal; Wenfeng Kang; Leon Li Wen Lim; Shekhar Krishnan; Kok-Siong Chen; Maria Isabel Achatz; Mawar Karsa; Jannah Shamsani; Arnold J Levine; Chang S Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

Review 3.  The Inherited p53 Mutation in the Brazilian Population.

Authors:  Maria Isabel Achatz; Gerard P Zambetti
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

Review 4.  Review: Ewing Sarcoma Predisposition.

Authors:  Pablo Gargallo; Yania Yáñez; Antonio Juan; Vanessa Segura; Julia Balaguer; Bárbara Torres; Silves Oltra; Victoria Castel; Adela Cañete
Journal:  Pathol Oncol Res       Date:  2019-10-26       Impact factor: 3.201

Review 5.  DNA and RNA quadruplex-binding proteins.

Authors:  Václav Brázda; Lucia Hároníková; Jack C C Liao; Miroslav Fojta
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

6.  RNA G-quadruplexes: emerging mechanisms in disease.

Authors:  Anne Cammas; Stefania Millevoi
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

7.  Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome.

Authors:  Kyoung Jin Park; Hyun Jung Choi; Soon Pal Suh; Chang Seok Ki; Jong Won Kim
Journal:  Ann Lab Med       Date:  2016-09       Impact factor: 3.464

8.  Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts.

Authors:  Mohammed Moquitul Haque; Pradnya Kowtal; Rajiv Sarin
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

9.  Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours.

Authors:  Amos Hong Pheng Loh; Joanne Ngeow; Sock Hoai Chan; Winston Chew; Nur Diana Binte Ishak; Weng Khong Lim; Shao-Tzu Li; Sheng Hui Tan; Jing Xian Teo; Tarryn Shaw; Kenneth Chang; Yong Chen; Prasad Iyer; Enrica Ee Kar Tan; Michaela Su-Fern Seng; Mei Yoke Chan; Ah Moy Tan; Sharon Yin Yee Low; Shui Yen Soh
Journal:  NPJ Genom Med       Date:  2018-11-15       Impact factor: 8.617

10.  Novel splicing in IGFN1 intron 15 and role of stable G-quadruplex in the regulation of splicing in renal cell carcinoma.

Authors:  Shiv Prakash Verma; Parimal Das
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.